Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004
Biochemical basis of inflammation in children with obstructive sleep apnea syndrome (OSAS) and in children with obesity Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011
Serum omentin levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
BNP or VEGF levels do not predict disease severity in obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Obstructive sleep apnea syndrome in obese patients: adiponectin levels Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Frequency of distribution of IL-1, IL-6 and TNFa gene polymorphism in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2006 - Metabolic control in obstructive sleep apnoea Year: 2006
S100B protein: A useful marker in obstructive sleep apnea syndrome Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Plasma levels of TNF in obstructive sleep apnea syndrome (OSA) before and after surgical intervention Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Relationship between obstructive sleep apnea syndrome (OSAS) and obesity, cholesterol disorders, blood pressure, and anatomical alterations Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006
Visfatin levels in sleep apnea syndrome Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007
C-reactive protein levels in obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004
Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004